Literature DB >> 7768602

Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease.

R A Kalish1, J M Leong, A C Steere.   

Abstract

The immunoglobulin G (IgG) antibody response to outer surface protein A (OspA) of Borrelia burgdorferi has been reported to occur late in the course of Lyme disease. To learn when reactivity to particular epitopes of OspA develops and whether the strength of particular responses correlates with the duration of arthritis and HLA-DR specificities, we determined the IgM and IgG responses by enzyme-linked immunosorbent assay in 128 patients with various manifestations of Lyme disease to full-length recombinant OspA and three OspA fragments which divided the protein approximately into thirds. Among the 10 patients who were followed serially, an early IgM response was often found to epitopes in all three fragments of OspA, sometimes accompanied by a weak IgG response, primarily to an epitope in the middle third of the protein. Months to years later, the seven patients who had prolonged or moderate episodes of arthritis developed strong IgG responses to OspA, especially to epitopes in the N-terminal and C-terminal fragments, that paralleled the course of the arthritis. In single serum samples from 128 patients, a similar pattern of IgM and IgG reactivity with OspA epitopes was seen in patients with early or late manifestations of the illness. Of the 80 patients with arthritis, 62 (78%) had IgG responses to OspA, usually with the strongest reactivity to the C-terminal fragment. In these patients, the strength of the IgG response to OspA correlated with the duration of arthritis; in HLA-DR4-positive patients, most of whom had chronic arthritis, this association was attributable to reactivity with the C-terminal fragment. Thus, patients with Lyme disease often have early responses to OspA, but those with prolonged arthritis do not develop IgG responses to certain epitopes of the protein until late in the illness. In patients with HLA-DR4, the strength of IgG reactivity with one or more epitopes in the C-terminal fragment of OspA correlates with the duration of arthritis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768602      PMCID: PMC173290          DOI: 10.1128/iai.63.6.2228-2235.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Antibody response in Lyme disease: evaluation of diagnostic tests.

Authors:  J E Craft; R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

2.  Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete.

Authors:  A G Barbour; W Burgdorfer; E Grunwaldt; A C Steere
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

3.  The early clinical manifestations of Lyme disease.

Authors:  A C Steere; N H Bartenhagen; J E Craft; G J Hutchinson; J H Newman; D W Rahn; L H Sigal; P N Spieler; K S Stenn; S E Malawista
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

4.  Lyme disease-a tick-borne spirochetosis?

Authors:  W Burgdorfer; A G Barbour; S F Hayes; J L Benach; E Grunwaldt; J P Davis
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

5.  Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection.

Authors:  B P Fung; G L McHugh; J M Leong; A C Steere
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis.

Authors:  L C Lim; D M England; B K DuChateau; N J Glowacki; R F Schell
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

7.  A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete.

Authors:  T R Howe; L W Mayer; A G Barbour
Journal:  Science       Date:  1985-02-08       Impact factor: 47.728

8.  The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.

Authors:  A R Pachner; A C Steere
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

9.  Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.

Authors:  L C Lim; D M England; B K DuChateau; N J Glowacki; J R Creson; S D Lovrich; S M Callister; D A Jobe; R F Schell
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis.

Authors:  B Lengl-Janssen; A F Strauss; A C Steere; T Kamradt
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  32 in total

1.  Complement receptor 3 binds the Borrelia burgdorferi outer surface proteins OspA and OspB in an iC3b-independent manner.

Authors:  Rodolfo C Garcia; Rossella Murgia; Marina Cinco
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement.

Authors:  J M Nowling; M T Philipp
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"?

Authors:  S M Callister; D A Jobe; R F Schell; C S Pavia; S D Lovrich
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

4.  Antibodies against specific proteins of and immobilizing activity against three strains of Borrelia burgdorferi sensu lato can be found in symptomatic but not in infected asymptomatic dogs.

Authors:  J W Hovius; K E Hovius; A Oei; D J Houwers; A P van Dam
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

5.  Characterization of an anti-Borrelia burgdorferi OspA conformational epitope by limited proteolysis of monoclonal antibody-bound antigen and mass spectrometric peptide mapping.

Authors:  V Legros; C Jolivet-Reynaud; N Battail-Poirot; C Saint-Pierre; E Forest
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

6.  Borrelia burgdorferi escape mutants that survive in the presence of antiserum to the OspA vaccine are killed when complement is also present.

Authors:  M Solé; C Bantar; K Indest; Y Gu; R Ramamoorthy; R Coughlin; M T Philipp
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

7.  Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection.

Authors:  M S Hanson; D R Cassatt; B P Guo; N K Patel; M P McCarthy; D W Dorward; M Höök
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 8.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters.

Authors:  L C Lim; D M England; N J Glowacki; B K DuChateau; R F Schell
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis.

Authors:  Bettina Panagiota Iliopoulou; Mireia Guerau-de-Arellano; Brigitte T Huber
Journal:  Arthritis Rheum       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.